Screener
AbCellera Biologics Inc. ABCL Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $145.07M+23.5% | $102.06M-44.6% | $128.51M-17.8% | $108.16M-28.7% | $117.44M-32.2% | ||
| $38.42M-45.1% | $39.16M-38.4% | $39.41M+23.2% | $71.25M— | $70.01M— | ||
| $7.58M— | $7.86M— | $6.34M— | —— | —— | ||
| $679.23M-8.5% | $664.6M-13.1% | $728.23M-3.1% | $695.14M-6.4% | $742.15M-3.8% | ||
| $47.81M0.0% | $47.81M0.0% | $47.81M0.0% | $47.81M0.0% | $47.81M0.0% | ||
| $16.86M-7.7% | $17.21M-7.6% | $38.38M-8.9% | $17.91M-16.6% | $18.26M-15.0% | ||
| $628.35M-4.8% | $642.52M+10.9% | $628.72M+3.2% | $660.85M+1.7% | $659.92M+3.0% | ||
| $1.31B-6.7% | $1.31B-2.8% | $1.36B-0.3% | $1.36B-2.6% | $1.4B-0.7% | ||
| $12.11M-62.2% | $20.81M-36.6% | $25.23M-26.6% | $31.77M-8.7% | $32.04M+20.5% | ||
| $20.71M+22.2% | $7.74M-58.8% | $13.53M0.0% | $15.69M+181% | $16.95M+165% | ||
| $53.19M-20.6% | $47.29M-37.3% | $64.31M-16.1% | $68.8M-13.5% | $67.02M-4.8% | ||
| $358.37M+9.3% | $321.74M+30.9% | $325.74M+43.0% | $323.15M+37.4% | $327.96M+41.9% | ||
| $411.56M+4.2% | $369.03M+14.9% | $390.05M+28.1% | $391.95M+24.5% | $394.99M+31.0% | ||
| $821.24M+3.7% | $816.53M+3.3% | $802.34M+3.2% | $794.47M+2.8% | $791.67M+2.8% | ||
| -$128.07M-450% | -$72.65M-202% | -$29.48M-125% | -$20.54M-114% | $36.58M-81.9% | ||
| $896.02M-11.0% | $938.08M-8.3% | $966.9M-8.4% | $964.04M-10.6% | $1.01B-9.4% | ||
| $1.31B-6.7% | $1.31B-2.8% | $1.36B-0.3% | $1.36B-2.6% | $1.4B-0.7% |
FAQ
- What are AbCellera Biologics Inc.'s total assets?
- AbCellera Biologics Inc. (ABCL) holds $1.3B in total assets, down 6.7% year over year.
- How much debt does AbCellera Biologics Inc. have?
- AbCellera Biologics Inc. carries $135.6M in total debt against $896.0M of shareholders' equity, a debt-to-equity ratio of 0.15.
- How much cash does AbCellera Biologics Inc. have?
- AbCellera Biologics Inc. holds $145.1M in cash and equivalents.
- Can AbCellera Biologics Inc. cover its short-term obligations?
- Its current ratio is 12.77 — current assets exceed current liabilities.
- Where does AbCellera Biologics Inc.'s balance sheet data come from?
- Every line is extracted from AbCellera Biologics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
